Christine A. Iacobuzio–Donahue

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

135h-index91.0kcitations1.0kworks2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(516), Cancer Genomics and Diagnostics(404), Epigenetics and DNA Methylation(131), Genetic factors in colorectal cancer(88), Cancer Cells and Metastasis(75)

Publications951 total

Transcriptomic Plasticity is a Hallmark of Metastatic Pancreatic Cancer
Cancer Research·2025Open Access
Supplementary Data from The Ratio of Key Metabolic Transcripts Is a Predictive Biomarker of Breast Cancer Metastasis to the Lung
2025Open Access
Safety and Feasibility of Intra-Arterial Treatment of Pancreatic Cancer Using an Emulsion of Ethiodized Oil plus Bumetanide in an Oncopig Model
Journal of Vascular and Interventional Radiology·2025
Acquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer
Clinical Cancer Research·2025· 1 citedOpen Access
Figure 3 from The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions
2025Open Access
Supplementary Table 16 from The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions
2025Open Access
Figure 4 from The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions
2025Open Access
Supplementary Table 17 from The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions
2025Open Access
Supplementary Figure 3 from The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions
2025Open Access
Figure 5 from The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions
2025Open Access
Supplementary Table 8 from The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions
2025Open Access
Supplementary Figure 1 from The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions
2025Open Access
Supplementary Table 14 from The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions
2025Open Access
Supplementary Table 15 from The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions
2025Open Access
Supplementary Table 11 from The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions
2025Open Access
Supplementary Table 13 from The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions
2025Open Access
Supplementary Table 4 from The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions
2025Open Access
Supplementary Figure 4 from The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions
2025Open Access
Supplementary Table 2 from The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions
2025Open Access
Supplementary Data from The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions
2025Open Access
page 1 of 48Next →

Frequent Co-authors

Ralph H. Hruban(24), Anirban Maitra(17), Michael Goggins(10), James R. Eshleman(10), Bert Vogelstein(7), Kenneth W. Kinzler(7), Christopher L. Wolfgang(7), Charles J. Yeo(7), Steven D. Leach(6), Alison P. Klein(6), Scott E. Kern(6), John L. Cameron(6), Elizabeth M. Jaffee(5), Victor E. Velculescu(5), Joseph M. Herman(5), Daniel A. Laheru(5), Siân Jones(4), Manuel Hidalgo(4), Nickolas Papadopoulos(4), David A. Tuveson(4)